← Leaderboards
Praveen B. Raju
Sloan-Kettering Inst Can Research
$4,034,338
Attributed
$7,199,266
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,199,266 · 4
By mechanism
R01$5,868,919 · 2
K08$869,410 · 1
R56$460,937 · 1
Top collaborators
- Daniel Alan Heller5 shared
- Matija Snuderl5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Daniel Alan Heller$9,871,986
- Adrienne A. Boire$2,755,815
- Andrea Ventura$13,315,692
- Alexandra L. Joyner$25,672,739
- Anna Marie Kenney$4,842,620
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellPathway InteractionsChildBrain NeoplasmsToxic EffectTumorGeneticGenomicsMouse ModelMolecularMedulloblastomaSonic Hedgehog PathwayPediatric NeoplasmPrimary EndpointNovel TherapeuticsRadiation TherapyMorbidity - Disease RateBrain TissueBrainAdultDrug Delivery SystemsDiagnosisBlood - Brain Barrier AnatomyChemotherapy
Grant awards (15)
Inducing Neural Maturation in Medulloblastoma by Targeting EZH2$686,834
R01 · FY2025 · NS
Inducing Neural Maturation in Medulloblastoma by Targeting EZH2$672,469
R01 · FY2024 · NS
Tumor-Selective Delivery Approaches for Medulloblastoma$577,523
R01 · FY2024 · NS
Inducing neural maturation in medulloblastoma by targeting EZH2$699,699
R01 · FY2023 · NS
Tumor-Selective Delivery Approaches for Medulloblastoma$603,031
R01 · FY2023 · NS
Inducing neural maturation in medulloblastoma by targeting EZH2$742,560
R01 · FY2022 · NS
Tumor-Selective Delivery Approaches for Medulloblastoma$608,977
R01 · FY2022 · NS
Tumor-Selective Delivery Approaches for Medulloblastoma$615,717
R01 · FY2021 · NS
Inducing neural maturation in medulloblastoma by targeting EZH2$460,937
R56 · FY2021 · NS
Tumor-Selective Delivery Approaches for Medulloblastoma$662,109
R01 · FY2020 · NS
Developmental Origins of Neural Tumors Using a Novel Genetic Inducible Analysis$177,449
K08 · FY2013 · NS · contact PI
Developmental Origins of Neural Tumors Using a Novel Genetic Inducible Analysis$177,449
K08 · FY2012 · NS · contact PI
Developmental Origins of Neural Tumors Using a Novel Genetic Inducible Analysis$171,504
K08 · FY2011 · NS · contact PI
Developmental Origins of Neural Tumors Using a Novel Genetic Inducible Analysis$171,504
K08 · FY2010 · NS · contact PI
Developmental Origins of Neural Tumors Using a Novel Genetic Inducible Analysis$171,504
K08 · FY2009 · NS · contact PI